Objectives

1.Review the history of the pneumococcal organism

2.Present the data on pneumococcal resistance to penicillin and ceftriaxone/cefotaxime over time and in relationship to vaccine use

3.Discuss as a section our collective thoughts about the use of vanco for presumptive therapy of bacterial meningitis

Session date: 
Monday, February 25, 2019 - 12:00pm to 1:00pm
Speaker Name: 
Daniel Johnson, MD
Location: 
UCMC C-400
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.